Golden Matrix Group’s Strategic Acquisitions Place It Ahead of the Game!
Golden Matrix Group, Inc. (OTCPINK: GMGI), formerly known as Source Gold Corp, announced the acquisition of a leading-edge gaming system from Gamefish Global...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
8 Reasons Why Misonix is a Good Stock for Your Portfolio!
Misonix, Inc. (NASDAQ: MSON) is building a highly differentiated surgical ultrasonic technology portfolio, to address and improve patient outcomes in neurosurgery, spine surgery,...
3 Biotech Stocks in Focus Now!
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to...
Commercial Vehicles Group Seeks to Electrify Its Future through Deal with XOS
Commercial Vehicle Group, Inc. (NASDAQ: CVGI), a leading developer of electric systems has announced a partnership with Xos, Inc, a leading commercial electric...
Can New Orders and Business Growth Help Vislink Buck the Trend?
Vislink Technologies, Inc. (NASDAQ: VISL), a global technology leader in wireless communications solutions, announced the receipt of an order in excess of $4...
Can BELBUCA repeat its record performance?
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a specialty pharmaceutical that seeks to address the unmet needs of patients suffering from Chronic and...
3 Renewable Energy Stocks with Tremendous Growth Potential!
Renewable Energy is derived from naturally replenishing sources such as Hydropower, Geothermal, Solar and Wind Energy. According to the U.S Energy Information Administration,...
Upcoming Catalysts Make MediWound a Stock to Watch Out for!
MediWound Ltd (NASDAQ: MDWD), a Company creating cutting-edge solutions for tissue repair and regeneration, recently announced its Q4 and Full-year 2020 Financial results. While...
Merck to Acquire Pandion Therapeutics for $1.85 Billion. Here’s Why!
Pandion Therapeutics, Inc. (NASDAQ: PAND), a clinical-stage biotechnology company developing modular biologics for autoimmune regulation, has entered into a definitive agreement with Merck...
